Evommune EVMN Operating lease right-of-use assets amortization expense
Operating lease right-of-use assets amortization expense at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's operating lease right-of-use assets amortization expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's operating lease right-of-use assets amortization expense?
- Evommune (EVMN) reported operating lease right-of-use assets amortization expense of $87.88K in Q1 2026.
- What does operating lease right-of-use assets amortization expense mean?
- The periodic expense recognized for the systematic reduction of the carrying value of right-of-use assets associated with operating leases. This reflects the consumption of the economic benefit of leased property, plant, or equipment over the lease term.